Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
In a cohort study in which 33 patients with giant congenital nevi were followed, 2 fatal melanomas developed, representing a relative risk approximately 1,000-fold greater than that in the general population (271), while in another study of 80 pediatric cases, 4 melanomas (3 of them fatal) occurred after an average follow-up of about 5 years (272)
doi: 10.1007/s00726-012-1361-4 38 LiuZXiaYZhangXLiuLTuSZhuWet al
Copyright 2026 Consumers Direct Insurance Services Blue Cross Blue Shield, and the Cross and Shield Symbols are registered service marks of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield Plans
cardiovascular death, nonfatal myocardial infarct, nonfatal stroke) for the GLP-1RA albiglutide, efpeglenatide, dulaglutide, liraglutide, and semaglutide ( The GLP-1RA liraglutide has also been approved for the treatment of obesity at a higher standard dose (3 mg once daily) compared to the standard dose used for T2D treatment (1.2 mg once daily) due to the results of the SCALE study program ( Development of dual- and triple-receptor agonists The pathophysiology of T2D and obesity is complex and heterogenous on an individual level
US$ 25.01
US$ 24.20
US$ 20.81
US$ 29.11
US$ 22.40
US$ 24.55
US$ 25.33
US$ 27.65
